3.1. Study Design, Setting, and Definitions
This single-blinded clinical trial was conducted employing a pretest-posttest design and registered at the Iranian Registry for Clinical Trials under the trial registration number IRCT20200813048398N1 on 2020-08-22. The patients admitted to the ICUs of the Imam Khomeini and Golestan hospitals of Ahvaz city, Iran were enrolled. The sample size was calculated according to the results of Jalalian et al.’s study (
17), considering the alpha of 5% and beta of 20% and including 10% attrition, using the relevant formula. The sample size in each group was calculated as 21 people.
The study subjects (N = 42) were selected out of patients admitted to ICUs and met our inclusion criteria (i.e., hospitalization in the ICU up to 24 hours after admission to the hospital, age of 18 - 65 years, feeding through an NG tube, being under MV for more than 24 hours, not being pregnant or obese (a body mass index above 40 kg/m
2), no liver disease, and no severe infection. Exclusion criteria were a change of feeding type from gavage to complete intravenous feeding and being transferred or discharged from the ICU (
Figure 1). Primary outcomes were the duration of connection to the ventilator and the length of ICU stay, and the secondary outcome was serum albumin level.
The study’s CONSORT flow diagram
In order to start the study, informed consent was obtained from the legal guardians of the patients who met the study’s entry criteria. Then, a history was taken from the patients, and a physical examination was performed by an ICU resident specialist. Medical information and patient records were obtained from the notions provided by the treatment team and by reviewing patients' files and recorded in a questionnaire and a checklist. Using a table of random numbers, the participants were randomly assigned to the intervention and control groups. The order of gavage was determined by the attending physician, but its content and amount were determined by a nutritionist.
In the intervention group, a standard Entera Meal solution, the product of Karen’s Pharmaceutical and Vital Food Supplements Company (Iran), was administered as the source of energy. The product was in the powder form, weighing 400 g, and contained 14% energy from a protein with a high biological value (whey) and milk, 32% energy from sunflower and coconut oils (source of MCT), 54% energy from Gluten-free low-lactose carbohydrates (maltodextrin), vitamins, minerals with enzyme complexes, and inulin.
To prepare 150 mL of the solution, 33 g (1 cup) of Entera Meal was added to 120 mL of chilled boiled water, creating a solution with 1 kcal energy per mL. To calculate the energy requirement of the patient, the patient’s ideal weight was determined. For patients appearing to have normal weight, the height was inserted into the formula used for BMI calculation; the BMI value was considered equal to 23 kg/m2, and the ideal weight was calculated. For patients appearing thin, BMI was equal to 18.5 kg/m2, and for those appearing fat, BMI was equal to 25 kg/m2. Accordingly, the energy required was determined. The amount of energy equivalent was considered to be 25 kcal per kg of the body weight for the first week and 30 kcal per kg of the body weight for the second week. Blood albumin levels were measured in both study groups before and after the intervention.
In the control group, a homemade solution prepared in the hospital’s kitchen was used without further interference or processing. Feeding was performed using an NG tube by the bolus infusion method and a 60-mL syringe. The feeding was started with 50 mL and increased up to 30 mL every three hours (6, 9, 12, 15, 18, and 21 hours) to reach the calculated energy within 48-72 hours. Serum albumin level was measured and analyzed before the intervention and at the end of the study period.
3.2. Data Collection
The data were collected using a demographic and medical information questionnaire, including age, gender, weight, and the type of the underlying disease, as well as a checklist for recording outcomes, including albumin level at the beginning and end of the study, the duration of the patient’s separation from the mechanical ventilator, and length of ICU admission. The validity of the questionnaire and the checklist was confirmed by 15 nursing faculty members.
3.3. Statistical Analysis
Data analysis was conducted using SPSS software version 22. Quantitative variables were reported as mean, and standard deviation, and qualitative variables were reported as frequency and percentage. The independent t-test was used to compare means between the study groups (for data with normal distribution), and the non-parametric Mann-Whitney U test was used for this purpose for variables with non-normal distribution. The chi-square or Fisher’s exact tests were used to compare the distribution of nominal variables between the two groups. In order to compare the means of continuous quantitative variables, first, their normality was checked using the Kolmogorov-Smirnov test, indicating that age and weight had normal distributions in both groups, but other variables (length of ICU hospitalization and serum albumin level before and after the intervention) had non-normal distribution.